Alois Langer

Last updated
Alois A. Langer
Born (1945-02-24) February 24, 1945 (age 78)
Pittsburgh, Pennsylvania
Education MIT, Carnegie Mellon
Occupation(s) Inventor, Scientist, Entrepreneur
Known forCo-Inventor of the Implantable Cardioverter-Defibrillator (ICD)
AwardsInduction into the Inventor’s Hall of Fame (2002)

Alois A. Langer (born February 24, 1945 in Pittsburgh, Pennsylvania) is an American biomedical engineer best known as one of the co-inventors of the Implantable Cardioverter Defibrillator (ICD).

Contents

Langer was inducted into the National Inventors Hall of Fame in 2002 for his contribution to developing the ICD. He studied electrical engineering at the Massachusetts Institute of Technology and completed his Ph.D. thesis at Carnegie Mellon University. In 1972, Langer became the chief biomedical engineer at MedRad Inc. and started work on the ICD project. In 1980, he oversaw the final testing and implantation of the device into a human patient. In 1990, Langer founded Cardiac Telecom Corporation and engaged in the development and marketing of telephonic cardiac monitoring systems. Langer currently lives in Forest Hills, Pennsylvania and works part-time as a Consultant.

Early life and education

Alois A. Langer, son of Westinghouse researcher and inventor also named Alois Langer, was born and raised in Pittsburgh, Pennsylvania. His father encouraged him to do something with his life that would work for the benefit of the people. Langer went study electrical engineering at the Massachusetts Institute of Technology where he graduated in 1967. After graduating from MIT, he pursued a combined PhD in electrical engineering and biotechnology at Carnegie Mellon University. He completed his thesis on multidimensional electrocardiographic analysis.

Development of the ICD

Medrad Inc

In 1972 Langer was hired by a company in Pittsburgh called Medrad Inc to work on the ICD project. The company president, Dr. Steve Heilman, had previously met with Baltimore cardiologist Dr. Michael Mirowski to discuss the possibility of developing the ICD. Mirowski had already patented the device and needed a company which would perfect it and manufacture it. Medrad took up the challenge of developing the ICD. Given Langer’s experience in electrocardiographic analysis and electrical engineering he was placed as the chief biomedical engineer of the ICD team. The fourth and last member of the initial team was Baltimore cardiopulmonary researcher Morton Mower.

Designing the ICD

As the engineering member of the ICD team, Langer was tasked with the design portion of development. He constructed both the miniature circuits on board as well as the mechanical packaging of the ICD. One of the time consuming tasks that Langer faced was the design of the electrode. This electrode needed to be reliable because it was the connection between the heart and the device that controlled all monitoring and defibrillation capabilities, however it also needed to be medically safe since it was being inserted into the body. Langer also had to design a battery that would power the device for several years without failing or causing any immune response in the body.

Testing The ICD

By 1976, Langer and the team had finished designing the device and started the rigorous and extensive testing process. For the next four years the ICT underwent animal models testing, design reviews, and other tests to verify that the device would indeed work. In 1980 the device was first implanted into a human subject at Johns Hopkins University. Langer was present in the operating room with the ICD device in hand; ready to be implanted into the first human. He was to test the device within the sterilized container just before it was to be implanted. Incidentally when he handed over the device to the nurse, it she lost control and dropped the device on the floor. Luckily Langer had brought duplicate for such incidents implanted this second copy successfully. Weeks later the team tested the device by inducing a potentially fatal arrhythmia. The defibrillator “took about 30-plus seconds or so” to restart the patient’s heart, says Heilman. Attending physicians were seconds away from giving up and jump-starting the heart with shock paddles when finally, says Heilman, “the device kicked in and did shock and did correct the rhythm.” By its completion, the ICD had 25+ patents.

Cardiac Telemetry

During his work on the ICD, Langer met with several patients and their families and noticed that lot of families were very anxious. The families worried when a cardiac event might recur and felt they needed to watch over their loved ones continuously. From this observation, Langer got the idea for developing a patient worn device that would monitor the heart rhythm 24 hours a day and relay any trouble to medical staff. It wasn't until 1989 that Langer began to pursue the idea, and began searching for funding and investors. In 1990 Langer founded Cardiac Telecom Corporation in Greensburg, PA and started development on telephonic monitoring systems. Initially Langer and his team worked on developing the HEARTrac I Cardiac Monitoring System. The HEARTrac system was designed for patient in hospital rooms as cheaper alternative to expensive ICU Monitoring or cardiac step down units. The device was approved in early 1995 by the FDA and shipment began later that year.

Telemetry @ Home

Next, the device was adapted so that it could be used for patients at home. The product worked in a manner similar to home alarm systems. Cardiac data was acquired by the unit worn on the patient and continuously transmitted wirelessly to a Tele-Link unit located next to the telephone. The Tele-Link system is preprogrammed with various cardiac event criteria, and if it detects any such criteria on the patient, it immediately transmits the electrocardiogram (ECG) to a remote monitoring location. At the monitoring location the ECG is analyzed and action is taken within 15–20 seconds. The system even allowed for the patient’s physician to dial in and request recent cardiac recordings. Langer is credited as the inventor of this home cardiac monitoring service, referred to as Telemetry @ Home.

Super Bowl XXX Demonstration

In 1996, Langer flew to Tempe, Arizona for the Super Bowl XXX in order to demonstrate the HEARTrac system. Langer set up the device on Myron Cope, the famous sports broadcaster for the game, in order to see “just how excited Cope gets during the big games”. The ECG from Cope was transmitted live to a cardiologist in Pittsburgh, who monitored it and provided feedback. The demonstration was proclaimed as a technological victory for Langer and his company Cardiac Telecom.

Later life

In 2002 Langer was inducted into the National Inventor’s Hall of Fame for his work on the ICD. On August 31, 2007, Langer’s Cardiac Telecom Corporation voluntarily filed for Chapter 11 Bankruptcy in order to reorganize the firm. Langer currently works as a Consultant and is involved in designing several non-medical alarm systems. Last known, he resides in Forest Hills, Pennsylvania.

Selected Patents

Related Research Articles

<span class="mw-page-title-main">Electrocardiography</span> Examination of the hearts electrical activity

Electrocardiography is the process of producing an electrocardiogram, a recording of the heart's electrical activity through repeated cardiac cycles. It is an electrogram of the heart which is a graph of voltage versus time of the electrical activity of the heart using electrodes placed on the skin. These electrodes detect the small electrical changes that are a consequence of cardiac muscle depolarization followed by repolarization during each cardiac cycle (heartbeat). Changes in the normal ECG pattern occur in numerous cardiac abnormalities, including cardiac rhythm disturbances, inadequate coronary artery blood flow, and electrolyte disturbances.

<span class="mw-page-title-main">Artificial cardiac pacemaker</span> Medical device

An artificial cardiac pacemaker is a medical device, nowadays always implanted, that generates electrical pulses delivered by electrodes to the chambers of the heart, either the upper atria or lower ventricles. Each pulse causes the targeted chambers to contract and pump blood, thus regulating the function of the electrical conduction system of the heart.

<span class="mw-page-title-main">Defibrillation</span> Treatment for life-threatening cardiac arrhythmias

Defibrillation is a treatment for life-threatening cardiac arrhythmias, specifically ventricular fibrillation (V-Fib) and non-perfusing ventricular tachycardia (V-Tach). A defibrillator delivers a dose of electric current to the heart. Although not fully understood, this process depolarizes a large amount of the heart muscle, ending the arrhythmia. Subsequently, the body's natural pacemaker in the sinoatrial node of the heart is able to re-establish normal sinus rhythm. A heart which is in asystole (flatline) cannot be restarted by a defibrillator, but would be treated by cardiopulmonary resuscitation (CPR).

<span class="mw-page-title-main">Implantable cardioverter-defibrillator</span> Medical device

An implantable cardioverter-defibrillator (ICD) or automated implantable cardioverter defibrillator (AICD) is a device implantable inside the body, able to perform defibrillation, and depending on the type, cardioversion and pacing of the heart. The ICD is the first-line treatment and prophylactic therapy for patients at risk for sudden cardiac death due to ventricular fibrillation and ventricular tachycardia.

<span class="mw-page-title-main">Holter monitor</span> Portable device for cardiac monitoring

In medicine, a Holter monitor is a type of ambulatory electrocardiography device, a portable device for cardiac monitoring for at least 24 hours.

<span class="mw-page-title-main">Ventricular tachycardia</span> Medical condition of the heart

Ventricular tachycardia is a fast heart rate arising from the lower chambers of the heart. Although a few seconds of VT may not result in permanent problems, longer periods are dangerous; and multiple episodes over a short period of time are referred to as an electrical storm. Short periods may occur without symptoms, or present with lightheadedness, palpitations, or chest pain. Ventricular tachycardia may result in ventricular fibrillation (VF) and turn into cardiac arrest. This conversion of the VT into VF is called the degeneration of the VT. It is found initially in about 7% of people in cardiac arrest.

<span class="mw-page-title-main">T wave alternans</span>

T wave alternans (TWA) is a periodic beat-to-beat variation in the amplitude or shape of the T wave in an electrocardiogram TWA was first described in 1908. At that time, only large variations could be detected. Those large TWAs were associated with increased susceptibility to lethal ventricular tachycardias.

Michel Mirowski was a physician who helped develop the implantable cardioverter-defibrillator (ICD).

Clinical cardiac electrophysiology, is a branch of the medical specialty of cardiology and is concerned with the study and treatment of rhythm disorders of the heart. Cardiologists with expertise in this area are usually referred to as electrophysiologists. Electrophysiologists are trained in the mechanism, function, and performance of the electrical activities of the heart. Electrophysiologists work closely with other cardiologists and cardiac surgeons to assist or guide therapy for heart rhythm disturbances (arrhythmias). They are trained to perform interventional and surgical procedures to treat cardiac arrhythmia.

<span class="mw-page-title-main">Transcutaneous pacing</span> Method of temporary stabilizing an individuals heartbeat

Transcutaneous pacing (TCP), also called external pacing, is a temporary means of pacing a patient's heart during a medical emergency. It should not be confused with defibrillation using a manual or automatic defibrillator, though some newer defibrillators can do both, and pads and an electrical stimulus to the heart are used in transcutaneous pacing and defibrillation. Transcutaneous pacing is accomplished by delivering pulses of electric current through the patient's chest, which stimulates the heart to contract.

<span class="mw-page-title-main">Cardiac monitoring</span>

Cardiac monitoring generally refers to continuous or intermittent monitoring of heart activity to assess a patient's condition relative to their cardiac rhythm. Cardiac monitoring is usually carried out using electrocardiography, which is a noninvasive process that records the heart's electrical activity and displays it in an electrocardiogram. It is different from hemodynamic monitoring, which monitors the pressure and flow of blood within the cardiovascular system. The two may be performed simultaneously on critical heart patients. Cardiac monitoring for ambulatory patients is known as ambulatory electrocardiography and uses a small, wearable device, such as a Holter monitor, wireless ambulatory ECG, or an implantable loop recorder. Data from a cardiac monitor can be transmitted to a distant monitoring station in a process known as telemetry or biotelemetry.

Morton Maimon Mower was an American cardiologist specializing in electrophysiology and the co-inventor of the automatic implantable cardioverter defibrillator. He served in several professional capacities at Sinai Hospital and Cardiac Pacemakers Inc. In 1996, he became the chairman and chief executive officer of Mower Research Associates. He was inducted into the National Inventors Hall of Fame in 2002 for the development of the automatic implantable cardioverter defibrillator with Michel Mirowski in the 1970s. He continued his research in the biomechanical engineering laboratories at Johns Hopkins University.

<span class="mw-page-title-main">Sinai Hospital (Maryland)</span> Hospital in Maryland, United States

Sinai Hospital is an American private hospital based in Baltimore, Maryland, that was founded in 1866 as the Hebrew Hospital and Asylum. It is now a Jewish-sponsored teaching hospital that provides care for patients in the greater Baltimore City, Baltimore County and surrounding communities. The implantable cardioverter-defibrillator (ICD) was invented here by the team of Dr. Michel Mirowski, Dr. Morton Mower, M. Stephen Heilman, and Alois Langer who are all in the National Inventors Hall of Fame for their achievement.

Marlin Stephen "Doc" Heilman is an American physician, entrepreneur and inventor. He is credited with inventions in the fields of contrast enhanced medical imaging, the first implantable cardioverter defibrillator or ICD, the first wearable defibrillator or LifeVest defibrillator, and heart assist devices. His first inventions, a flow controlled angiographic injector and pressure tolerant disposable angiographic syringes, advanced the fields of radiology and cardiology by improving the diagnostic image quality and eliminating the imaging risk of blood borne disease transmission from patient to patient. He founded Medrad Inc, now part of Bayer Healthcare, to manufacture and supply these imaging devices on a worldwide basis. In 2013, an estimated 65 million medical imaging procedures were performed using Medrad products.

<span class="mw-page-title-main">Cardiac resynchronization therapy</span>

Cardiac resynchronisation therapy is the insertion of electrodes in the left and right ventricles of the heart, as well as on occasion the right atrium, to treat heart failure by coordinating the function of the left and right ventricles via a pacemaker, a small device inserted into the anterior chest wall.

A wearable cardioverter defibrillator (WCD) is a non-invasive, external device for patients at risk of sudden cardiac arrest (SCA). It allows physicians time to assess their patient's arrhythmic risk and make appropriate plans. It is a leased device. A summary of the device, its technology and indications was published in 2017 and reviewed by the EHRA Scientific Documents Committee.

Biotronik is a limited partnership multi-national cardiovascular biomedical research and technology company, headquartered in Berlin, Germany.

Defibrillation threshold indicates the minimum amount of energy needed to return normal rhythm to a heart that is beating in a cardiac dysrhythmia. Typical examples are the minimum amount of energy, expressed in joules, delivered by external defibrillator paddles or pads, required to break atrial fibrillation and restore normal sinus rhythm. Other common scenarios are restoring normal rhythm from atrial flutter, ventricular tachycardia or ventricular fibrillation. The defibrillation threshold ranking in these settings, from lowest to highest, would be, in order, ventricular tachycardia, atrial flutter, atrial fibrillation, ventricular fibrillation. The highest amount of energy that an external defibrillator can deliver at the present time is 360 joules biphasic. In clinical practice, the real threshold can be approximated but not exactly established, since the defibrillating shock can be delivered only once. Certain medications, in particular sotalol, tend to lower such threshold, while others, such as amiodarone, may increase it.

<span class="mw-page-title-main">Subcutaneous implantable defibrillator</span>

Subcutaneous implantable cardioverter defibrillator, or S-ICD, is an implantable medical device for detecting and terminating ventricular tachycardia and ventricular fibrillation in patients at risk of sudden cardiac arrest. It is a type of implantable cardioverter defibrillator but unlike the transvenous ICD, the S-ICD lead is placed just under the skin, leaving the heart and veins untouched.

Cyborg data mining is the practice of collecting data produced by an implantable device that monitors bodily processes for commercial interests. As an android is a human-like robot, a cyborg, on the other hand, is an organism whose physiological functioning is aided by or dependent upon a mechanical/electronic device that relies on some sort of feedback.

References

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.